Global Fabry Disease Therapeutic Market Analysis 2013-2018 and Forecast 2019-2024

Table of Contents

1 Industry Overview

• 1.1 Fabry Disease Therapeutic Industry
  • 1.1.1 Overview
  • 1.1.2 Development of Fabry Disease Therapeutic
• 1.2 Market Segment
  • 1.2.1 Upstream
  • 1.2.2 Downstream
• 1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

• 2.1 Policy
• 2.2 Economics
• 2.3 Sociology
• 2.4 Technology

3 Fabry Disease Therapeutic Market by Type

• 3.1 By Type
  • 3.1.1 Enzyme Replacement Therapy
  • 3.1.2 Alternative therapies
• 3.2 Market Size
• 3.3 Market Forecast

4 Major Companies List

4.Fabry Disease Therapeutic Amicus therapeutics (Company Profile, Sales Data etc.)

• 4.2 Shire (Company Profile, Sales Data etc.)
• 4.3 Genzyme-Sanofi (Company Profile, Sales Data etc.)
• 4.4 Protalix (Company Profile, Sales Data etc.)
• 4.5 Sanofi-Aventis LLC (Company Profile, Sales Data etc.)
• 4.6 Novartis Pharmaceuticals (Company Profile, Sales Data etc.)
• 4.7 Pfizer (Company Profile, Sales Data etc.)
• 4.8 Bristol-Myers Squibb Company (Company Profile, Sales Data etc.)
• 4.9 GlaxoSmithKline plc (Company Profile, Sales Data etc.)
• 4.10 Amgen Inc. (Company Profile, Sales Data etc.)
• 4.11 Teva pharmaceutical Industries Ltd. (Company Profile, Sales Data etc.)
• 4.12 Merc & Co. (Company Profile, Sales Data etc.)
• 4.13 AbbVie Inc. (Company Profile, Sales Data etc.)
• 4.14 Takeda Pharmaceutical Co. Ltd. (Company Profile, Sales Data etc.)
• 4.15 Green Cross Corp. (Company Profile, Sales Data etc.)

5 Market Competition

• 5.1 Company Competition
• 5.2 Regional Market by Company

6 Demand by End Market

• 6.1 Demand Situation
  • 6.1.1 Demand in Hospitals
  • 6.1.2 Demand in Clinics
  • 6.1.3 Demand in Others
• 6.2 Regional Demand Comparison
• 6.3 Demand Forecast

7 Region Operation

• 7.1 Regional Production
• 7.2 Regional Market
• 7.3 by Region
  • 7.3.1 North America
    • 7.3.1.1 Overview
    • 7.3.1.2 by Country (U.S., Canada, Mexico)
  • 7.3.2 Europe
    • 7.3.2.1 Overview
    • 7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
  • 7.3.3 Asia-Pacific
    • 7.3.3.1 Overview
    • 7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
  • 7.3.4 South America
    • 7.3.4.1 Overview
    • 7.3.4.2 by Country (Brazil, Argentina etc.)
  • 7.3.5 Middle East & Africa
    • 7.3.5.1 Overview
    • 7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
• 7.4 Regional Import & Export
• 7.5 Regional Forecast

8 Marketing & Price

• 8.1 Price and Margin
  • 8.1.1 Price Trends
  • 8.1.2 Factors of Price Change
  • 8.1.3 Manufacturers Gross Margin Analysis
• 8.2 Marketing Channel

9 Research Conclusion

List of Tables

Table Upstream Segment of Fabry Disease Therapeutic

Table Application Segment of Fabry Disease Therapeutic

Table Global Fabry Disease Therapeutic Market 2013-2024, by Application, in USD Million

Table Major Company List of Enzyme Replacement Therapy

Table Major Company List of Alternative therapies

Table Global Fabry Disease Therapeutic Market 2013-2018, by Type, in USD Million

Table Global Fabry Disease Therapeutic Market 2013-2018, by Type, in Volume

Table Global Fabry Disease Therapeutic Market Forecast 2019-2024, by Type, in USD Million

Table Global Fabry Disease Therapeutic Market Forecast 2019-2024, by Type, in Volume

Table Amicus therapeutics Overview List

Table Fabry Disease Therapeutic Business Operation of Amicus therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Shire Overview List

Table Fabry Disease Therapeutic Business Operation of Shire (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Genzyme-Sanofi Overview List

Table Fabry Disease Therapeutic Business Operation of Genzyme-Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Protalix Overview List

Table Fabry Disease Therapeutic Business Operation of Protalix (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Sanofi-Aventis LLC Overview List

Table Fabry Disease Therapeutic Business Operation of Sanofi-Aventis LLC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Novartis Pharmaceuticals Overview List

Table Fabry Disease Therapeutic Business Operation of Novartis Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Pfizer Overview List

Table Fabry Disease Therapeutic Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Bristol-Myers Squibb Company Overview List

Table Fabry Disease Therapeutic Business Operation of Bristol-Myers Squibb Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table GlaxoSmithKline plc Overview List

Table Fabry Disease Therapeutic Business Operation of GlaxoSmithKline plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Amgen Inc. Overview List

Table Fabry Disease Therapeutic Business Operation of Amgen Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Teva pharmaceutical Industries Ltd. Overview List

Table Fabry Disease Therapeutic Business Operation of Teva pharmaceutical Industries Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Merc & Co. Overview List

Table Fabry Disease Therapeutic Business Operation of Merc & Co. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table AbbVie Inc. Overview List

Table Fabry Disease Therapeutic Business Operation of AbbVie Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Takeda Pharmaceutical Co. Ltd. Overview List

Table Fabry Disease Therapeutic Business Operation of Takeda Pharmaceutical Co. Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Green Cross Corp. Overview List

Table Fabry Disease Therapeutic Business Operation of Green Cross Corp. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global Fabry Disease Therapeutic Sales Revenue 2013-2018, by Company, in USD Million

Table Global Fabry Disease Therapeutic Sales Revenue Share, by Company, in USD Million

Table Global Fabry Disease Therapeutic Sales Volume 2013-2018, by Company, in Volume

Table Global Fabry Disease Therapeutic Sales Volume Share 2013-2018, by Company, in Volume

Table Major Consumers List and Overview

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Fabry Disease Therapeutic Demand Forecast 2019-2024, by Application, in USD Million

Table Fabry Disease Therapeutic Demand Forecast 2019-2024, by Application, in Volume

Table Fabry Disease Therapeutic Production 2013-2018, by Region, in USD Million

Table Fabry Disease Therapeutic Production 2013-2018, by Region, in Volume

Table Global Fabry Disease Therapeutic Market 2013-2018, by Region, in USD Million

Table Global Fabry Disease Therapeutic Market Share 2013-2018, by Region, in USD Million

Table Global Fabry Disease Therapeutic Market 2013-2018, by Region, in Volume

Table Global Fabry Disease Therapeutic Market Share 2013-2018, by Region, in Volume

Table North America Fabry Disease Therapeutic Market Size 2013-2018, by Country, in USD Million

Table North America Fabry Disease Therapeutic Market Size 2013-2018, by Country, in Volume

Table Europe Fabry Disease Therapeutic Market Size 2013-2018, by Country, in USD Million

Table Europe Fabry Disease Therapeutic Market Size 2013-2018, by Country, in Volume

Table Asia-Pacific Fabry Disease Therapeutic Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Fabry Disease Therapeutic Market Size 2013-2018, by Country, in Volume

Table South America Fabry Disease Therapeutic Market Size 2013-2018, by Country, in USD Million

Table South America Fabry Disease Therapeutic Market Size 2013-2018, by Country, in Volume

Table Middle East & Africa Fabry Disease Therapeutic Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Fabry Disease Therapeutic Market Size 2013-2018, by Country, in Volume

Table Fabry Disease Therapeutic Market Forecast 2019-2024, by Region, in USD Million

Table Fabry Disease Therapeutic Market Forecast 2019-2024, by Region, in Volume

Table Price Factors List

List of Figures

Figure Global Fabry Disease Therapeutic Market Growth 2013-2018, by Type, in USD Million

Figure Global Fabry Disease Therapeutic Market Growth 2013-2018, by Type, in Volume

Figure North America Fabry Disease Therapeutic Market Concentration, in 2018

Figure Europe Fabry Disease Therapeutic Market Market Concentration, in 2018

Figure Asia-Pacific Fabry Disease Therapeutic MMarket Concentration, in 2018

Figure South America Fabry Disease Therapeutic Market Concentration, in 2018

Figure Middle East & Africa Fabry Disease Therapeutic Market Concentration, in 2018

Figure Fabry Disease Therapeutic Demand in Hospitals, 2013-2018, in USD Million

Figure Fabry Disease Therapeutic Demand in Hospitals, 2013-2018, in Volume

Figure Fabry Disease Therapeutic Demand in Clinics, 2013-2018, in USD Million

Figure Fabry Disease Therapeutic Demand in Clinics, 2013-2018, in Volume

Figure Fabry Disease Therapeutic Demand in Others, 2013-2018, in USD Million

Figure Fabry Disease Therapeutic Demand in Others, 2013-2018, in Volume

Figure North America Fabry Disease Therapeutic Market Size and Growth 2013-2018, in USD Million

Figure North America Fabry Disease Therapeutic Market Size and Growth 2013-2018, in Volume

Figure Europe Fabry Disease Therapeutic Market Size and Growth 2013-2018, in USD Million

Figure Europe Fabry Disease Therapeutic Market Size and Growth 2013-2018, in Volume

Figure Asia-Pacific Fabry Disease Therapeutic Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Fabry Disease Therapeutic Market Size and Growth 2013-2018, in Volume

Figure South America Fabry Disease Therapeutic Market Size and Growth 2013-2018, in USD Million

Figure South America Fabry Disease Therapeutic Market Size and Growth 2013-2018, in Volume

Figure Middle East & Africa Fabry Disease Therapeutic Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Fabry Disease Therapeutic Market Size and Growth 2013-2018, in Volume

Figure Marketing Channels Overview